BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4069366)

  • 21. The role of acetylcholine receptor antibodies in myasthenia gravis.
    Appel SH; Elias SB; Chauvin P
    Fed Proc; 1979 Sep; 38(10):2381-5. PubMed ID: 478014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphologic and immunopathologic findings in myasthenia gravis and in congenital myasthenic syndromes.
    Engel AG
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):577-89. PubMed ID: 6249893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic modulation of human myotube acetylcholine receptor by myasthenic sera. Serum titer determines receptor internalization rate.
    Tzartos SJ; Sophianos D; Zimmerman K; Starzinski-Powitz A
    J Immunol; 1986 May; 136(9):3231-8. PubMed ID: 3958494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myasthenia gravis: demonstration of membrane attack complex in muscle end-plates.
    Fazekas A; Komoly S; Bózsik B; Szobor A
    Clin Neuropathol; 1986; 5(2):78-83. PubMed ID: 3519034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An electrophysiological study of the effects of myasthenia gravis sera and complement on rat isolated muscle fibres.
    Mozrzymas JW; Lorenzon P; Riviera AP; Tedesco F; Ruzzier F
    J Neuroimmunol; 1993 Jun; 45(1-2):155-62. PubMed ID: 8331159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
    Kuncl RW; Drachman DB; Adams R; Lehar M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):582-9. PubMed ID: 8246131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acetylcholine receptors of aneurally cultured human and animal muscle.
    Askanas V; Engel WK; Ringel SP; Bender AN
    Neurology; 1977 Nov; 27(11):1019-22. PubMed ID: 562996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Refractoriness to a second episode of experimental myasthenia gravis. Correlation with AChR concentration and morphologic appearance of the postsynaptic membrane.
    Corey AL; Richman DP; Agius MA; Wollmann RL
    J Immunol; 1987 May; 138(10):3269-75. PubMed ID: 3494763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-fiber electromyography in experimental autoimmune myasthenia gravis.
    Verschuuren JJ; Spaans F; De Baets MH
    Muscle Nerve; 1990 Jun; 13(6):485-92. PubMed ID: 2366822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myasthenia gravis. Study of humoral immune mechanisms by passive transfer to mice.
    Toyka KV; Drachman DB; Griffin DE; Pestronk A; Winkelstein JA; Fishbeck KH; Kao I
    N Engl J Med; 1977 Jan; 296(3):125-31. PubMed ID: 831074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental myasthenia gravis. A murine system.
    Berman PW; Patrick J
    J Exp Med; 1980 Jan; 151(1):204-23. PubMed ID: 7350247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.
    Newsom-Davis J; Pinching AJ; Vincent A; Wilson SG
    Neurology; 1978 Mar; 28(3):266-72. PubMed ID: 564482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patient-specific anti=acetylcholine receptor antibody patterns in myasthenia gravis.
    Savage-Marengo T; Harrison R; Lunt GG; Behan PO
    J Neurol Neurosurg Psychiatry; 1980 Apr; 43(4):316-20. PubMed ID: 7373331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylcholine receptor and thymus in experimental autoimmune myasthenia gravis and experimental myositis.
    Ueno S; Wada K; Kang J; Takahashi M; Tarui S
    Clin Exp Immunol; 1982 Dec; 50(3):563-71. PubMed ID: 7165999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis.
    Lindstrom JM; Einarson BL; Lennon VA; Seybold ME
    J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myasthenia gravis: antibodies to extracellularly exposed antigenic determinants of acetylcholine receptor.
    Oda K; Shibasaki H
    Neurology; 1986 Oct; 36(10):1374-7. PubMed ID: 2429233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiological effects of myasthenic serum factors studied in mouse muscle.
    Lerrick AJ; Wray D; Vincent A; Newsom-Davis J
    Ann Neurol; 1983 Feb; 13(2):186-91. PubMed ID: 6830177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intrathecal immunoactivation in the patients with myasthenia gravis--autoantibodies in the cerebrospinal fluid].
    Yamanaka N; Araki S
    Rinsho Shinkeigaku; 1989 Jan; 29(1):13-7. PubMed ID: 2743683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.